Education
About Us
Working with TipRanks
Follow Us
Kringle Pharma, Inc. (JP:4884)
:4884
4884 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥527.00 - ¥1,328.00
Previous CloseN/A
Volume217.60K
Average Volume (3M)90.31K
Market Cap
¥5.38B
Enterprise Value¥3.84B
Total Cash (Recent Filing)¥2.10B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta1.11
Next Earnings
May 09, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-119.38
Shares Outstanding6,837,200
10 Day Avg. Volume128,800
30 Day Avg. Volume90,310
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Kringle Pharma, Inc. News
PremiumCompany Announcements
Kringle Pharma Releases Updated Analyst Report to Enhance Investor Insight
PremiumCompany Announcements
Kringle Pharma Reports Flat Sales and Continued Losses
PremiumCompany Announcements
Kringle Pharma Releases New Analyst Report
PremiumCompany Announcements
Kringle Pharma Releases Insightful Analyst Report---
4884 FAQ
What was Kringle Pharma, Inc.’s price range in the past 12 months?
Kringle Pharma, Inc. lowest stock price was ¥527.00 and its highest was ¥1328.00 in the past 12 months.
What is Kringle Pharma, Inc.’s market cap?
Kringle Pharma, Inc.’s market cap is ¥5.38B.
When is Kringle Pharma, Inc.’s upcoming earnings report date?
Kringle Pharma, Inc.’s upcoming earnings report date is May 09, 2025 which is in 31 days.
How were Kringle Pharma, Inc.’s earnings last quarter?
Kringle Pharma, Inc. released its earnings results on Feb 07, 2025. The company reported -¥31.23 earnings per share for the quarter, missing the consensus estimate of N/A by -¥31.23.
Is Kringle Pharma, Inc. overvalued?
According to Wall Street analysts Kringle Pharma, Inc.’s price is currently Overvalued.
Does Kringle Pharma, Inc. pay dividends?
Kringle Pharma, Inc. does not currently pay dividends.
What is Kringle Pharma, Inc.’s EPS estimate?
Kringle Pharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kringle Pharma, Inc. have?
Kringle Pharma, Inc. has 6,837,200 shares outstanding.
What happened to Kringle Pharma, Inc.’s price movement after its last earnings report?
Kringle Pharma, Inc. reported an EPS of -¥31.23 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.148%.
Which hedge fund is a major shareholder of Kringle Pharma, Inc.?
Currently, no hedge funds are holding shares in JP:4884
---
Company Description
Kringle Pharma, Inc.
Kringle Pharma, Inc. engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines. The company develops HGF products for the treatment of acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scar, and acute kidney injury. Kringle Pharma, Inc. was incorporated in 2001 and is based in Ibaraki, Japan.
---
Technical Analysis
Chugai Pharmaceutical Co
―
Daiichi Sankyo Company
―
Eisai Co
―
Shionogi & Co
―
Chiome Bioscience Inc.
―
---